Molina Healthcare (MOH) is up about 3% in Monday trading, with the move aligning with a near-term catalyst: the company is scheduled to release first-quarter 2026 results after the market close on Wednesday, April 22, 2026, followed by a conference call on Thursday, April 23, 2026. Investors also had fresh confirmation that senior management plans to reaffirm the company’s 2026 full-year outlook that was originally provided on February 6, 2026, helping support sentiment into earnings. (investors.molinahealthcare.com)

Molina’s 2026 baseline has been a focal point for the stock since the company introduced full-year 2026 guidance that included expected premium revenue of roughly $42 billion and adjusted earnings of at least $5.00 per diluted share. That guidance also flagged specific headwinds, including contract implementation costs and weaker performance in its traditional Medicare Advantage Part D (MAPD) product, which the company said it plans to exit for 2027. With the shares trading around $150, Monday’s rebound suggests some investors are leaning toward “no negative surprise” positioning heading into the April earnings update. (sec.gov)

The next decisive data point is the April 22 earnings release and the April 23 call, where investors will be listening for any changes to full-year 2026 expectations, updated color on medical cost trends, and progress on contract transitions. If management reiterates the February outlook without new incremental cost pressure, the near-term relief rally could extend; conversely, any commentary implying higher medical-loss pressure or contract friction could quickly reverse the move. (investors.molinahealthcare.com)